<code id='0AF84C598B'></code><style id='0AF84C598B'></style>
    • <acronym id='0AF84C598B'></acronym>
      <center id='0AF84C598B'><center id='0AF84C598B'><tfoot id='0AF84C598B'></tfoot></center><abbr id='0AF84C598B'><dir id='0AF84C598B'><tfoot id='0AF84C598B'></tfoot><noframes id='0AF84C598B'>

    • <optgroup id='0AF84C598B'><strike id='0AF84C598B'><sup id='0AF84C598B'></sup></strike><code id='0AF84C598B'></code></optgroup>
        1. <b id='0AF84C598B'><label id='0AF84C598B'><select id='0AF84C598B'><dt id='0AF84C598B'><span id='0AF84C598B'></span></dt></select></label></b><u id='0AF84C598B'></u>
          <i id='0AF84C598B'><strike id='0AF84C598B'><tt id='0AF84C598B'><pre id='0AF84C598B'></pre></tt></strike></i>

          entertainment

          entertainment

          author:entertainment    Page View:556

          The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

          “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

          advertisement

          Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          Novo Nordisk touts Wegovy study, but still struggling with supply
          Novo Nordisk touts Wegovy study, but still struggling with supply

          LISELOTTESABROE/Scanpix/AFPviaGettyImagesThereleaseofNovoNordisk’slatestearningsreportonThursdayprov

          read more
          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more

          Pence says 'crackpot lawyers' told Trump what he wanted to hear

          1:11RepublicanpresidentialcandidateandformerVicePresidentMikePencespeaksduringastopattheIndianaState